Hypoxia signalling through mTOR and the unfolded protein response in cancer

Wouters, Bradly G., Koritzinsky, Marianne·2008·Nature Reviews Cancer

Cited by (884)

Items 401–500 of 884

  1. Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance
    Abdul Halim Shaikat, S.M. Asadul Karim Azad, Md. Azizur Rahman Tamim, Mohammed Sailim Ullah, Mohammad Nurul Amin, Mofazzal K. Sabbir, Md. Towhidul Islam Tarun, Md Saqline Mostaq, Shohana Sabrin, Md Zihad Mahmud et al. · 2025 · Cancer Pathogenesis and Therapy
  2. Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma
    Maria Rosaria Abbattista, Stephen M. F. Jamieson, Yongchuan Gu, Jennifer Elisabeth Nickel, Susan M. Pullen, Adam Vorn Patterson, William Robert Wilson, Christopher P. Guise · 2015 · Cancer Biology & Therapy
  3. High Expression of Glucose Transporter 1 on Primary Lesions of Esophageal Squamous Cell Carcinoma is Associated with Hematogenous Recurrence
    Hiroshi Sawayama, Takatsugu Ishimoto, Masayuki Watanabe, Naoya Yoshida, Yoshifumi Baba, Hidetaka Sugihara, Daisuke Izumi, Junji Kurashige, Hideo Baba · 2013 · Annals of Surgical Oncology
  4. Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer
    Pasquale Cirone, Catharine J. Andresen, Jeetendra R. Eswaraka, Patrick B. Lappin, Cedo M. Bagi · 2014 · Cancer Chemotherapy and Pharmacology
  5. A Comprehensive MicroRNA Expression Profile Related to Hypoxia Adaptation in the Tibetan Pig
    Bo Zhang, Yangzong Qiangba, Peng Shang, Zhixiu Wang, Jun Ma, Liyuan Wang, Hao Zhang · 2015 · PLoS ONE
  6. Luteolin inhibits angiogenesis of the M2‑like TAMs via the downregulation of hypoxia inducible factor‑1α and the STAT3 signalling pathway under hypoxia
    Binbo Fang, Xuehai Chen, Minmin Wu, Hongru Kong, Guanyu Chu, Zhenxu Zhou, Chunwu Zhang, Bicheng Chen · 2018 · Molecular Medicine Reports
  7. APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells
    Kristian M. Jacobsen, Nikolaj L. Villadsen, Thomas Tørring, Camilla Bak Nielsen, Trine Salomón, Morten Muhlig Nielsen, Michail Tsakos, Christian Sibbersen, Carsten Scavenius, Rikke Nielsen et al. · 2018 · Cell chemical biology
  8. Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
    Y. Romero, Arnoldo Aquíno-Gálvez · 2021 · International Journal of Molecular Sciences
  9. ATF4 orchestrates a program of BH3-only protein expression in severe hypoxia
    Luke Pike, Kanchan Phadwal, Anna Katharina Simon, Adrian Llewellyn Harris · 2012 · Molecular Biology Reports
  10. Modulation of the Akt Pathway Reveals a Novel Link with PERK/eIF2α, which Is Relevant during Hypoxia
    Matı́as Blaustein, Daniela Pérez-Munizaga, Manuel Alejandro Sánchez, Carolina Urrutia, Alicia Grande, Guillermo Risso, Anabella Srebrow, Jennifer Alfaro, Alejandro Colman‐Lerner · 2013 · PLoS ONE
  11. Identification of an AAA ATPase VPS4B-Dependent Pathway That Modulates Epidermal Growth Factor Receptor Abundance and Signaling during Hypoxia
    Hong Lin, Xu Li, Jo-Lin Chen, Xiuzhu Sun, Fariba Norouziyan Cooper, Yun-Ru Chen, Wenyu Zhang, Yiyin Chung, Angela Li, Chun-Ting Cheng et al. · 2012 · Molecular and Cellular Biology
  12. Molecular Pathogenesis of Sporadic Melanoma and Melanoma-Initiating Cells
    Yunyi Kong, Suresh M. Kumar, Xiaowei Xu · 2010 · Archives of Pathology & Laboratory Medicine
  13. The changing paradigm of tumour response to irradiation
    Richard Peter Hill · 2016 · British Journal of Radiology
  14. DDIT4 regulates mesenchymal stem cell fate by mediating between HIF1α and mTOR signalling
    Borzo Gharibi, Mandeep S. Ghuman, Francis J. Hughes · 2016 · Scientific Reports
  15. Drugging the unfolded protein response in acute leukemias
    Behzad Kharabi Masouleh, Éric Chevet, Jens Panse, Edgar Jost, Michael E O'Dwyer, Tim Bruemmendorf, Afshin Samali A · 2015 · Journal of Hematology & Oncology
  16. Disruption of Kv1.3 Channel Forward Vesicular Trafficking by Hypoxia in Human T Lymphocytes
    Ameet Ajit Chimote, Zerrin Kuras, Laura Conforti · 2011 · Journal of Biological Chemistry
  17. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of ΔNp63α expression and promote breast cancer metastasis independent of HIF1α
    Hu Chen, Shuhan Yu, Ruidong Ma, Liyuan Deng, Yong Yi, Mengmeng Niu, Chuan Shan Xu, Zhi‐Xiong Jim Xiao · 2024 · Cell Death and Differentiation
  18. Educational paper: pathogenesis of infantile haemangioma, an update 2014 (part I)
    Sherief R. Janmohamed, Gerard C. Madern, Peter C. J. de Laat, Arnold P. Oranje · 2014 · European Journal of Pediatrics
  19. AKT as locus of cancer multidrug resistance and fragility
    Ziv Manasija Radisavljevic · 2012 · Journal of Cellular Physiology
  20. Functional characterization of EI24-induced autophagy in the degradation of RING-domain E3 ligases
    Sushil Devkota, Hyobin Jeong, Yunmi Kim, Muhammad Ali, Jae-il Roh, Daehee Hwang, Han‐Woong Lee · 2016 · Autophagy
  21. Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer
    Da‐Qiang Li, Rakesh Kumar · 2015 · Advances in cancer research
  22. Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions
    Shiro Koizume, Yohei Miyagi · 2015 · Cancers
  23. AMPK-mediated cardioprotection of atorvastatin relates to the reduction of apoptosis and activation of autophagy in infarcted rat hearts.
    Qing Li, Qiu‐Ting Dong, Yuejin Yang, Xiaqiu Tian, Jin Chen, Peisen Huang, Leipei Jiang, Gui-hao Chen · 2016 · PubMed Central
  24. A Golgi-associated redox switch regulates catalytic activation and cooperative functioning of ST6Gal-I with B4GalT-I
    Hassinen, Antti, Khoder-Agha, Fawzi, Khosrowabadi, Elham, Mennerich, Daniela, Harrus, Deborah, Noel, Maxence, Dimova, Elitsa Y., Glumoff, Tuomo, Harduin-Lepers, Anne, Kietzmann, Thomas et al. · 2019 · Redox Biology
  25. Translational regulator eIF2α in tumor
    Qiaoli Zheng, Jingjia Ye, Jiang Cao · 2014 · Tumor Biology
  26. A new ER-specific photosensitizer unravels 1O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT
    Adán Pinto, Yohan Macé, Fleur Drouet, Emilie Bony, Romain Boidot, Nihed Draoui, Irina I. Lobysheva, Cyril Corbet, Florence Polet, Ruben Martherus et al. · 2015 · Oncogene
  27. A HIF–LIMD1 negative feedback mechanism mitigates the pro‐tumorigenic effects of hypoxia
    Daniel E. Foxler, Katherine S. Bridge, John Gordon Foster, Paul Grevitt, Sean Curry, Kunal Shah, Kathryn M Davidson, A. Nagano, Emanuela Gadaleta, Hefin I. Rhys et al. · 2018 · EMBO Molecular Medicine
  28. A redox ruthenium compound directly targets PHD2 and inhibits the HIF1 pathway to reduce tumor angiogenesis independently of p53
    Vania Vidimar, Cynthia Licona, Ricardo Cerón‐Camacho, Éric Guérin, Pierre Coliat, Aïna Venkatasamy, Moussa Ali, Dominique Guénot, Ronan Le Lagadec, Alain C. Jung et al. · 2018 · Cancer Letters
  29. Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells
    Damien Reita, Cyril Bour, Radhia Benbrika, Audrey Groh, Erwan Pencreach, Éric Guérin, Dominique Guénot · 2019 · Cancers
  30. On translational regulation and EMT
    Valentina E. Evdokimova, Cristina E. Tognon, Poul H. B. Sorensen · 2012 · Seminars in Cancer Biology
  31. Regulation of Autophagy by Metabolic and Stress Signaling Pathways in the Heart
    Youngil Lee, Hwa-Youn Lee, Åsa B. Gustafsson · 2012 · Journal of Cardiovascular Pharmacology
  32. Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth
    Charlène Rico, Marie-Noëlle Laguë, Pavine L. C. Lefèvre, Mayra F. Tsoi, Aurore Dodelet-Devillers, Vikas Kumar, Évelyne Lapointe, Marilène Paquet, Marie‐Ève Nadeau, Derek Boerboom · 2012 · Carcinogenesis
  33. The role of HIF in immunity
    Daniel Philip Gale, Patrick Henry Maxwell · 2009 · The International Journal of Biochemistry & Cell Biology
  34. Targeting hypoxia in the treatment of small cell lung cancer
    Jennifer Bryant, Suzanne L. Meredith, Kaye Janine Williams, Anne E. White · 2014 · Lung Cancer
  35. Role of extracellular signal-regulated kinase (ERK)1/2 in multicellular resistance to docetaxel in MCF-7 cells
    Kang · 2010 · International Journal of Oncology
  36. Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns
    Alejandra Wu Chuang, Oliver Kepp, Guido Kroemer, Lucillia Bezu · 2019 · International review of cytology
  37. Bad neighbours: hypoxia and genomic instability in prostate cancer
    Jack Ashton, Robert Glen Bristow · 2020 · British Journal of Radiology
  38. Hypoxic regulation of the PERK/ATF4/LAMP3‐arm of the unfolded protein response in head and neck squamous cell carcinoma
    Anika Nagelkerke, Fred C.G.J. Sweep, Hanneke Stegeman, Reidar A. Grenman, Johannes H.A.M. Kaanders, Johan Bussink, Paul N. Span · 2014 · Head & Neck
  39. Chronic Hypoxia-Induced Autophagy Aggravates the Neuropathology of Alzheimer’s Disease through AMPK-mTOR Signaling in the APP Swe /PS1 dE9 Mouse Model
    Hui Liu, Hongyan Qiu, Qian Xiao, Weidong Le · 2015 · Journal of Alzheimer s Disease
  40. Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulation
    Giorgia Mandili, Elisa Alchera, Simone Merlin, Chiara Imarisio, Bangalore R. Chandrashekar, Chiara Riganti, Alberto Bianchi, Francesco Novelli, Antonia Follenzi, Rita Carini · 2014 · Journal of Hepatology
  41. Proteomic analysis reveals diverse proline hydroxylation-mediated oxygen-sensing cellular pathways in cancer cells
    Tong Zhou, Luke N. Erber, Bing Liu, Yankun Gao, Hai‐Bin Ruan, Yue Chen · 2016 · Oncotarget
  42. A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
    Xinyi Zhao, Wen Zeng, Hong Wei Xu, Zihan Sun, Yingxin Hu, Beibei Peng, Jennifer D. McBride, Jiangtao Duan, Juan Deng, Bin Zhang et al. · 2023 · Science Translational Medicine
  43. Immunostimulatory activity of lifespan-extending agents
    José Manuel Bravo‐San Pedro, Laura Senovilla · 2013 · Aging
  44. From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers
    Fariz Nurwidya, Fumiyuki Takahashi, Kunihiko Minakata, Akiko Murakami, Kazuhisa Takahashi · 2012 · Anatomy & Cell Biology
  45. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α
    Juan Ma, Ying Zi Jiang, Hui Rong Shi, Chunliu Mi, Jing Li, Ji‐Xing Nan, Xue Zhen Wu, Jung Joon Lee, Xuejun Jin · 2013 · European Journal of Pharmacology
  46. Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice
    Toshio Nishikawa, Munenori Takaoka, Toshiaki Ohara, Yasuko Tomono, Huifang Hao, Xiaohong Bao, Takuya Fukazawa, Zhigang Wang, Kazufumi Sakurama, Yasuhiro Fujiwara et al. · 2013 · Cancer Biology & Therapy
  47. Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation
    Michal Sheffer, Amos J. Simon, Jasmine Jacob‐Hirsch, Gideon Rechavi, Eytan Domany, David Givol, Gabriella D’Orazi · 2011 · Oncotarget
  48. Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells
    Chenxiao Yu, J. Xue, Wei Zhu, Y. Jiao, Shu-Yu Zhang, Jian-Ping Cao · 2014 · Tumor Biology
  49. Kinome Sirna Screen Identifies SMG-1 as a Negative Regulator of Hypoxia-inducible Factor-1α in Hypoxia
    Run-Qiang Chen, Qingkai Yang, Yanling Chen, Vasco A. Oliveira, William S. Dalton, Colleen Fearns, Jiing‐Dwan Lee · 2009 · Journal of Biological Chemistry
  50. mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate
    Hélia Fernandes, João Moura, Eugénia Carvalho · 2021 · Stem Cell Reviews and Reports
  51. Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia
    Sara E. Patterson, Caroline N. Dealy · 2014 · Developmental Dynamics
  52. Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells
    Evelyn Zeindl‐Eberhart, Lydia Brandl, Sibylle Liebmann, Steffen Ormanns, Silvio K. Scheel, Thomas Brabletz, Thomas Kirchner, Andreas Jung · 2014 · PLoS ONE
  53. mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
    Zhuo Wang, Wei Jin, Hongchuan Jin, Xian Wang · 2014 · BioMed Research International
  54. Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA
    Antony Herold Prabhu, Bhaswati Sarcar, Soumen Kahali, Yuan Shan, Prakash Chinnaiyan · 2012 · PLoS ONE
  55. Oxygen tension level and human viral infections
    F. Morinet, Luana Casetti, Jean-Hugues François, Claude Capron, Sylvie Pillet · 2013 · Virology
  56. Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer
    Shiro Koizume, Shin Ito, Yoshiyasu Nakamura, Mitsuyo Yoshihara, Mitsuko Furuya, Roppei Yamada, Etsuko Miyagi, Fumiki Hirahara, Yasuo Takano, Yohei Miyagi · 2015 · Molecular Cancer
  57. Proteolytic Cleavage of AMPKα and Intracellular MMP9 Expression Are Both Required for TLR4-Mediated mTORC1 Activation and HIF-1α Expression in Leukocytes
    Zhiyong Zhang, Louis F. Amorosa, Susette M. Coyle, Marie Macor, Sara E. Lubitz, Jeffrey L. Carson, Morris J. Birnbaum, Leonard Y. Lee, Beatrice Haimovich · 2015 · The Journal of Immunology
  58. The ER stress sensor PERK luminal domain functions as a molecular chaperone to interact with misfolded proteins
    Peng Wang, Jingzhi Li, Bingdong Sha · 2016 · Acta Crystallographica Section D Structural Biology
  59. Glycoprotein biomarkers and analysis in chronic obstructive pulmonary disease and lung cancer with special focus on serum immunoglobulin G
    Andras Komaromy, Balazs Reider, Gábor Járvás, András Guttman · 2020 · Clinica Chimica Acta
  60. Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1α Stabilization and Expression of Its Downstream Targets
    van Gisbergen, Marike W., Offermans, Kelly, Voets, An M., Lieuwes, Natasja G., Biemans, Rianne, Hoffmann, Roland F., Dubois, Ludwig J., Lambin, Philippe · 2020 · Frontiers in Oncology
  61. UPRmt and coordinated UPRER in type 2 diabetes
    Zhanfang Kang, Feng Chen, Wanhui Wu, Rui R Liu, Tianda Chen, Fang Xu · 2022 · Frontiers in Cell and Developmental Biology
  62. Effects of acute hypoxia on nutrient metabolism and physiological function in turbot, Scophthalmus maximus
    Qiang Ma, Houguo Xu, Yuliang Wei, Mengqing Liang · 2023 · Fish Physiology and Biochemistry
  63. Hypoxia Negatively Regulates Antimetastatic PEDF in Melanoma Cells by a Hypoxia Inducible Factor-Independent, Autophagy Dependent Mechanism
    Asunción Fernández‐Barral, José Luis Orgaz, Valentí Gómez, Luis del Peso, María José Calzada, Benilde Jiménez · 2012 · PLoS ONE
  64. High CO2 alters the hypoxia response of the Pacific whiteleg shrimp (Litopenaeus vannamei) transcriptome including known and novel hemocyanin isoforms
    Jillian G. Johnson, Matthew R. Paul, Casey D. Kniffin, Paul E. Anderson, Louis E. Burnett, Karen G. Burnett · 2015 · Physiological Genomics
  65. Metabolic response of glioblastoma cells associated with glucose withdrawal and pyruvate substitution as revealed by GC-MS
    Henry Oppermann, Yonghong Ding, Jeevan Sharma, Mandy Berndt‐Paetz, Jürgen Meixensberger, Frank Gaunitz, Claudia Birkemeyer · 2016 · Nutrition & Metabolism
  66. Deficient carbonic anhydrase 9 expression in UPR-impaired cells is associated with reduced survival in an acidic microenvironment
    Twan van den Beucken, Chantal H.M.A. Ramaekers, Kasper M. A. Rouschop, Marianne Koritzinsky, Bradly G. Wouters · 2009 · Radiotherapy and Oncology
  67. Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype
    Sandy Che-Eun S. Lee, Andrea Hye An Pyo, Marianne Koritzinsky · 2023 · Science Advances
  68. The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer
    Mei Ding, Theodorus van der Kwast, Ravi Nagaraj Vellanki, Warren D. Foltz, Trevor D. McKee, Nahum Sonenberg, Pier Paolo Pandolfi, Marianne Koritzinsky, Bradly G. Wouters · 2018 · Molecular Cancer Research
  69. Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
    Noushin Nabavi, Kevin L. Bennewith, Andrew Churg, Yuzhuo Z. Wang, Colin C. Collins, Luciano Mutti · 2017 · Genes & Cancer
  70. Prevention of CCAAT/Enhancer-binding Protein β DNA Binding by Hypoxia during Adipogenesis
    Young-Kwon Park, Hyunsung Park · 2009 · Journal of Biological Chemistry
  71. Knockdown of glucose-regulated protein 78 abrogates chemoresistance of hypopharyngeal carcinoma cells to cisplatin induced by unfolded protein in response to severe hypoxia
    Lihong Pi, XIAOMING LI, QI SONG, Yupeng Shen, Xiuying Lu, Bin Di · 2013 · Oncology Letters
  72. Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells
    Teona Ontikatze, Justine Rudner, René Handrick, Claus Belka, Verena Jendrossek · 2014 · Frontiers in Oncology
  73. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
    Helena Pópulo, Regina Caldas, José Manuel Lopes, Joana Pardal, Valdemar Máximo, Paula Soares · 2015 · Expert Opinion on Therapeutic Targets
  74. Hypoxia-inducible factor cell non-autonomously regulates C. elegans stress responses and behavior via a nuclear receptor
    Corinne L. Pender, Howard Robert Horvitz · 2018 · eLife
  75. IRE1 Endoribonuclease Activity Modulates Hypoxic HIF-1α Signaling in Human Endothelial Cells
    Adrianna Moszyńska, James F. Collawn, Rafał Bartoszewski · 2020 · Biomolecules
  76. The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment
    Jan Theys, Barry Jutten, Ludwig Jerome Dubois, Kasper M. A. Rouschop, Roland K. Chiu, Younan Li, Kim Paesmans, Philippe Lambin, Guido Lammering, Bradly G. Wouters · 2009 · Radiotherapy and Oncology
  77. Interaction between hypoxia, AKT and HIF-1 signaling in HNSCC and NSCLC: implications for future treatment strategies
    Hanneke Stegeman, Paul N. Span, Wenny J.M. Peeters, Marieke MG Verheijen, Reidar A. Grenman, Tineke W.H. Meijer, Johannes H.A.M. Kaanders, Johan Bussink · 2016 · Future Science OA
  78. Self‐Assembled pH‐Sensitive Fluoromagnetic Nanotubes as Archetype System for Multimodal Imaging of Brain Cancer
    Chiara Villa, Marcello Campione, Beatriz Santiago González, Francesco Alessandrini, Silvia Erratico, Ileana Zucca, Maria Grazia Bruzzone, Laura Virginia Forzenigo, Paolo Malatesta, Michele Mauri et al. · 2018 · Advanced Functional Materials
  79. Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
    Marilyn Wegge, Rüveyda Dok, Sandra Nuyts · 2021 · Cancers
  80. Oxygen Sensing: A Common Crossroad in Cancer and Neurodegeneration
    Annelies Quaegebeur, Peter Carmeliet · 2010 · Current topics in microbiology and immunology
  81. Hypoxia-inducible factor-1: A possible link between inhalational anesthetics and tumor progression?
    Hailin Zhao, Masae Iwasaki, Jiali Yang, Sinead Savage, Daqing Ma · 2014 · Acta anaesthesiologica Taiwanica
  82. Multiple cutaneous infantile haemangiomas and the risk of internal haemangioma
    Astrid Vredenborg, Sherief R. Janmohamed, Peter C. J. de Laat, Gerard C. Madern, A. P. Oranje · 2013 · British Journal of Dermatology
  83. Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition
    Ian Damerill, Kyle K. Biggar, Majida Abu Shehab, Shawn S.‐C. Li, Thomas Jansson, Madhulika B. Gupta · 2015 · Molecular Endocrinology
  84. Ribosome profiling reveals translational regulation of mammalian cells in response to hypoxic stress
    Zhiwen Jiang, Jiaqi Yang, Aimei Dai, Yuming Wang, Wei Li, Zhi Xie · 2017 · BMC Genomics
  85. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα
    Zhenzhen Ma, Ruohan Yu, Jinxia Zhao, Lin Sun, Leilei Jian, Changhong Li, Xiangyuan Liu · 2019 · Inflammation Research
  86. Enzyme-Activated Generation of Reactive Oxygen Species from Heterocyclic N-Oxides under Aerobic and Anaerobic Conditions and Its Relevance to Hypoxia-Selective Prodrugs
    Xiulong Shen, Kent S. Gates · 2019 · Chemical Research in Toxicology
  87. Transcriptomic responses of juvenile Pacific whiteleg shrimp,Litopenaeus vannamei, to hypoxia and hypercapnic hypoxia
    Charles K. Rathburn, Natasha J. Sharp, James C. Ryan, Marion G. Neely, Matthew Cook, Robert W Chapman, Louis E. Burnett, Karen G. Burnett · 2013 · Physiological Genomics
  88. The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells
    Leila Jahangiri, Tala Ishola, Perla Pucci, Ricky M. Trigg, João D. Pereira, John Alexander Williams, Megan L. Cavanagh, Georgios V. Gkoutos, Loukia Tsaprouni, Suzanne Dawn Turner · 2021 · Cancers
  89. Fluid Shear Stress-Induced Exosomes from Liver Cancer Cells Promote Activation of Cancer-Associated Fibroblasts via IGF2-PI3K Axis
    Tang Feng, Fei Fang, Chunhe Zhang, Tiantian Li, Jia He, Yang Shen, Hongchi Yu, Xiaoheng Liu · 2022 · Frontiers in Bioscience-Landmark
  90. The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs
    Francis W. Hunter, Jagdish Kumar Jaiswal, Daniel Hurley, H.D. Sarath Liyanage, Sarah P. McManaway, Yongchuan Gu, Susan Richter, Jingli Wang, Moana Tercel, Cristin Gregor Print et al. · 2014 · Biochemical Pharmacology
  91. 4′,6-Dihydroxy-4-methoxyisoaurone Inhibits the HIF-1α Pathway Through Inhibition of Akt/mTOR/p70S6K/4E-BP1 Phosphorylation
    Chunliu Mi, Juan Ma, Hui Rong Shi, Jing Li, Fei Wang, Jung Joon Lee, Xuejun Jin · 2014 · Journal of Pharmacological Sciences
  92. Percolation transition of cooperative mutational effects in colorectal tumorigenesis
    Dongkwan Shin, Jong‐Hoon Lee, Jeong‐Ryeol Gong, Kwang‐Hyun Cho · 2017 · Nature Communications
  93. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
    Simone de Leve, Florian Wirsdörfer, Verena Jendrossek · 2019 · Cancers
  94. Toxicity of Metal Oxide Nanoparticles: Looking through the Lens of Toxicogenomics
    Andrey Boyadzhiev, Dongmei Wu, Mary‐Luyza Avramescu, Andrew Williams, Pat E. Rasmussen, Sabina S. Halappanavar · 2023 · International Journal of Molecular Sciences
  95. Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons
    Yifeng Wang, Shengguang Ding · 2024 · Journal of Translational Medicine
  96. Novel Metastasis-Related Gene CIM Functions in the Regulation of Multiple Cellular Stress–Response Pathways
    Kiyoshi Yanagisawa, Hiroyuki Konishi, Chinatsu Arima, Shuta Tomida, Toshiyuki Takeuchi, Yukako Shimada, Yasushi Yatabe, Tetsuya Mitsudomi, Hirotaka Osada, Takashi Takahashi · 2010 · Cancer Research
  97. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas
    Plabon Kumar Das, Farhadul Islam, Robert Anthony Smith, Alfred King-yin Lam · 2021 · Frontiers in Oncology
  98. Hypoxia-induced transcriptional stress is mediated by ROS-induced R-loops
    Tiffany S Ma, Katja R. Worth, Conor Maher, Natalie Ng, Chiara Beghè, Natalia Gromak, Anna M. Rose, Ester M. Hammond · 2023 · Nucleic Acids Research
  99. GSK-3β-dependent downregulation of γ-taxilin and αNAC merge to regulate ER stress responses
    Yuka Hotokezaka, Ikuo Katayama, Klaus van Leyen, Takashi Nakamura · 2015 · Cell Death and Disease
  100. EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages
    N. MOHAMMED, María Elena Rodríguez, Vanesa García‐Barberán, J.M. GARCIA, Gemma Domínguez, Cristina Peña, Mercedes Herrera, Irene Gómez, Raquel Díaz, Beatriz Soldevilla et al. · 2011 · Oncology Letters